Model
Edge
BioCryst Pharmaceuticals Inc
0001718020
Filing type
144
Filing date
Nov 12, 2025
Updated
Nov 13, 2025 ยท 8:21 AM
Copy reference
Filing
144
Notice of Proposed Sale of Securities